Ovoca Bio (LSE:OVB) Accounts Payable & Accrued Expense : £0.38 Mil (As of Jun. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Ovoca Bio Accounts Payable & Accrued Expense?

Ovoca Bio's quarterly accounts payable & accrued expense declined from Jun. 2023 (£0.41 Mil) to Dec. 2023 (£0.26 Mil) but then increased from Dec. 2023 (£0.26 Mil) to Jun. 2024 (£0.38 Mil).

Ovoca Bio's annual accounts payable & accrued expense increased from Dec. 2021 (£0.32 Mil) to Dec. 2022 (£1.12 Mil) but then declined from Dec. 2022 (£1.12 Mil) to Dec. 2023 (£0.26 Mil).

Ovoca Bio Accounts Payable & Accrued Expense Historical Data

The historical data trend for Ovoca Bio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ovoca Bio Accounts Payable & Accrued Expense Chart

Ovoca Bio Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.20

0.32

1.12

0.26

Ovoca Bio Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.10	1.12	0.41	0.26	0.38

Ovoca Bio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Ovoca Bio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ovoca Bio PLC (LSE:OVB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

OVXA:Ireland OVB.GB:UK

Address

17 Pembroke Street Upper, Dublin, IRL, D02 AT22

Website

https://www.ovocabio.com

Ovoca Bio PLC is a life science investment company. The company is engaged in investing in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. The group has two business segments, bio-pharmaceutical and investment, which are operated principally in Russian Federation and investment activities operated from Bermuda, and with administrative activities in the Republic of Ireland. Its product candidate includes IVIX - Libicore - a novel synthetic peptide, administrated through a nasal spray.